Abstract
This study was aimed to test whether PIK3CA, BRAF and RAS are mutated in nasopharyngeal carcinomas (NPCs) and, if so, to further determine whether such mutations affect patients’ survival. For this purpose, a total of 73 NPCs were subjected to mutational analyses for PIK3CA (exons 4, 7, 9, and 20), BRAF (codon 600), and RAS (codons 12, 13 and 61). Clinicopathological characteristics were correlated to the mutation data. Survival rates were compared with the log-rank test. The result showed that the mutation rate of PIK3CA in NPC (n = 73) was 9.6%, whereas both BRAF (n = 65) and RAS (n = 45) were wild type in every specimen with adequate DNA for analysis. PIK3CA mutation was slightly influenced by sex (P = 0.0418, Fisher’s exact test), but had no significant relationship to other clinicopathological characteristics. Disease-specific survival was not significantly affected by PIK3CA mutations (P = 0.8825, log-rank test), albeit it was slightly better in younger patients (≤35 vs. >35 years of age) (P = 0.0477). These findings show that mutated PI3K may be involved in the NPC tumorigenesis but does not affect patient’s prognosis, suggesting that PI3K is a potential target in NPC for targeted therapeutics using specific kinase inhibitors.
Similar content being viewed by others
References
Liebowitz D. Nasopharyngeal carcinoma: the Epstein–Barr virus association. Semin Oncol. 1994;21:376–81.
Hirayama T. Descriptive and analytical epidemiology of nasopharyngeal cancer. IARC Sci Publ. 1978;20:167–89.
Parkin DM, Muir CS. Cancer incidence in five continents. Comparability and quality of data. IARC Sci Publ. 1992;120:45–173.
Lee AW, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys. 1992;23:261–70.
Sham JS, Choy D, Choi PH. Nasopharyngeal carcinoma: the significance of neck node involvement in relation to the pattern of distant failure. Br J Radiol. 1990;63:108–13.
Huang SC, Lui LT, Lynn TC. Nasopharyngeal cancer: study III. A review of 1206 patients treated with combined modalities. Int J Radiat Oncol Biol Phys. 1985;11:1789–93.
Lee AW, et al. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976–1985: survival after local recurrence. Int J Radiat Oncol Biol Phys. 1993;26:773–82.
Sham JS, Choy D. Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients. Br J Radiol. 1990;63:51–8.
Samuels Y, et al. High frequency of mutations of the PIK3CA gene in human cancers. Science. 2004;304:554. doi:10.1126/science.1096502.
Saal LH, et al. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. Cancer Res. 2005;65:2554–9. doi:10.1158/0008-5472-CAN-04-3913.
Wymann MP, Pirola L. Structure and function of phosphoinositide 3-kinases. Biochim Biophys Acta. 1998;1436:127–50.
Kumar V, Cotran RS, Robbins SL. Neoplasia. In: Kumar V, Cotran RS, Robbins SL, editors. Robbins basic pathology. 7th ed. Philadelphia: Saunders Press; 2003. p. 180.
Davies H, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949–54. doi:10.1038/nature00766.
Kim KH, Kang DW, Kim SH, Seong IO, Kang DY. Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population. Yonsei Med J. 2000;45:818–21.
Namba H, et al. Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers. J Clin Endocrinol Metab. 2003;88:4393–7. doi:10.1210/jc.2003-030305.
Rajagopalan H, et al. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature. 2002;418:934. doi:10.1038/418934a.
Li SY, Rong MN, Grieu F, Iacopetta B. PIK3CA mutations in breast cancer are associated with poor outcome. Breast Cancer Res Treat. 2006;96:91–5. doi:10.1007/s10549-005-9048-0.
Broderick DK, et al. Mutations of PIK3CA in anaplastic oligodendrogliomas, high-grade astrocytomas, and medulloblastomas. Cancer Res. 2004;64:5048–50. doi:10.1158/0008-5472.CAN-04-1170.
Li VS, et al. Mutations of PIK3CA in gastric adenocarcinoma. BMC Cancer. 2005;5:29. doi:10.1186/1471-2407-5-29.
Qiu W, et al. PIK3CA mutations in head and neck squamous cell carcinoma. Clin Cancer Res. 2006;12:1441–6. doi:10.1158/1078-0432.CCR-05-2173.
Wang Y, Helland A, Holm R, Kristensen GB, Borresen-Dale AL. PIK3CA mutations in advanced ovarian carcinoma. Hum Mutat. 2005;25:322. doi:10.1002/humu.9316.
Wu G, et al. Somatic mutation and gain of copy number of PIK3CA in human breast cancer. Breast Cancer Res. 2005;7:R609–16. doi:10.1186/bcr1262.
Or YY, Hui AB, To KF, Lam CN, Lo KW. PIK3CA mutations in nasopharyngeal carcinoma. Int J Cancer. 2006;118:1065–7. doi:10.1002/ijc.21444.
Hildesheim A, Leoine PH. Etiology of nasophargngeal carcinoma: a review. Epidemiol Rev. 1993;15:466–85.
Poirier S, et al. Volatile nitrosamine levels and genotoxicity of food samples from high-risk areas for nasopharyngeal carcinoma before and after nitrosation. Int J Cancer. 1989;44:1088–94. doi:10.1002/ijc.2910440625.
Yu MC, Ho JH, Lai SH, Henderson BE. Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong. Cancer Res. 1986;46:956–61.
Teo P, et al. Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys. 1996;36:291–304. doi:10.1016/S0360-3016(96)00323-9.
Qin DX, et al. Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation. Cancer. 1988;61:1117–24. doi:10.1002/1097-0142(19880315)61:6<1117::AID-CNCR2820610611>3.0.CO;2-J.
Lee AW, et al. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2005;61:1107–16. doi:10.1016/j.ijrobp.2004.07.702.
Acknowledgments
This work was supported in part by NSC 95-2320-B-195-001 from National Science Council, Taiwan, and MMH-E-96002 from Mackay Memorial Hospital, Taipei, Taiwan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chou, CC., Chou, MJ. & Tzen, CY. PIK3CA mutation occurs in nasopharyngeal carcinoma but does not significantly influence the disease-specific survival. Med Oncol 26, 322–326 (2009). https://doi.org/10.1007/s12032-008-9124-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12032-008-9124-5